Cryoablation of Intercostal Nerves for Post-Operative Pain Management in Opioid-Tolerant Patients

Study summary

The main objective study is to compare the use of the cryoSPHERE probe to the standard-of-care method for pain management of patients receiving robotic-assisted thoracoscopic surgery, including reductions in opioid pain medication use and the development of post-surgical morbidity.

Ask AI to explain this study

Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedcryoSPHERE Ablation and Bupivacaine

The study team can explain what participation involves.

Who it may be forPain · Pain, Postoperative

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Mar 24, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Unknown

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?The Methodist Hospital Research Institute

Study sponsor

Study overview

What this study is about

Purpose: Treatment
Study type: Interventional
Phase: Not applicable
Sponsor: The Methodist Hospital Research Institute
Interventions being studied: Device: cryoSPHERE Ablation; Drug: Bupivacaine

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Surgery→

Study topics

After surgery (adjuvant)→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Male and female patients 18-90 years of age
Diagnosis requiring robotic-assisted thoracoscopic surgery
Daily opioid use for at least 30 days consecutively at any point during the last 12 months prior to surgery or using opioids at the time of study enrollment
Experimental group only: agreement and consent to comply with all aspects of the study protocol and data collection, including follow-up contact.

Reasons someone may not be able to joinExclusion criteria

Previous major surgery at the operative site (thoracotomy)
Allergy to aluminum
Allergy to plastics
Allergy to bupivacaine
Shingles disease
Demyelinating illnesses
Involvement with other interventional studies

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Houston Methodist Research InstituteHouston, Texas

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 24, 2023. Always confirm current availability with the study team.

View original record ↗